Medovex Corp. entered into a partnership with Technology Consult Berlin GmbH for distribution of its Denervex system in Germany.
Technology Consult is expected to provide sales, marketing and distribution services.
On March 13, the company said the reimbursement authority in Germany had renewed reimbursement payment coding for its Denervex system technology for the treatment of the facet joint syndrome for 2017.
The coding was released in the diagnosis-related group system in 2017 in Germany and allows for hospitals and outpatient centers to receive reimbursement for the use of the system.
Denervex is not yet commercially available in the EU and the U.S. The system is not yet FDA cleared.